Zobrazeno 1 - 10
of 76
pro vyhledávání: '"Hiroki Asano"'
Publikováno v:
Medicina, Vol 59, Iss 11, p 1963 (2023)
Background and Objectives: One type of immune-related adverse event caused by immune checkpoint inhibitors (ICIs) is pituitary-related adverse events. The management of pituitary-related adverse events is important because they can be fatal if not tr
Externí odkaz:
https://doaj.org/article/31a077ddbe0745bcbfcb5ec02d47fb1b
Autor:
Hiroki Asano, Takahiro Hiraoka, Yusuke Seki, Teppei Shibata, Hiromi Osada, Takanori Saruta, Natsuko Hatsusaka, Fukumi Fujikake, Yoshiaki Tabata, Cellina Mhina, Anna Sanyiwa, Tetsuro Oshika, Hiroshi Sasaki
Publikováno v:
PLoS ONE, Vol 14, Iss 9, p e0222297 (2019)
PurposeTo investigate the distribution of corneal spherical aberration (SA) in Tanzanian people of African descent, and to examine the correlation between corneal SA and ocular parameters.DesignCross-sectional population-based study.MethodsResidents
Externí odkaz:
https://doaj.org/article/eac714eaedb0463f8daf348c16e41c49
Publikováno v:
Oncol Lett
Lenvatinib (LEN), a multitarget tyrosine kinase inhibitor, is a standard therapeutic agent for hepatocellular carcinoma, but the high incidence of adverse events (AEs) related to LEN treatment often necessitates treatment discontinuation. The present
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::04029a2abddc877e14e1bd3d5637f19d
https://europepmc.org/articles/PMC10018281/
https://europepmc.org/articles/PMC10018281/
Publikováno v:
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.
Introduction We aimed to compare the safety of lenvatinib as first-line treatment for unresectable hepatocellular carcinoma (HCC) in patients with Child-Pugh A (CP-A) and Child-Pugh B (CP-B) and to determine the adverse events (AEs) that cause dose r
Autor:
Saeko, Taga, Hiroki, Asano, Mina, Iwai, Shoya, Takenaka, Akihiro, Moriya, Takashi, Otsuka, Michio, Kimura, Tomoaki, Yoshimura
Publikováno v:
Gan to kagaku ryoho. Cancerchemotherapy. 49(10)
A new nivolumab and pembrolizumab monotherapy regimen with double the conventional dose and longer dosing intervals( the new regimen)has been approved. Here, we report the incidence of immune-related adverse events(irAEs)in the early phase of switchi
Publikováno v:
Advances in therapy. 38(11)
This study evaluated the efficacy and safety of diquafosol ophthalmic solution (DQS) in soft contact lens (SCL)-related dry eye using artificial tear as a control. This study enrolled 26 patients with SCL-related dry eye. DQS and artificial tears (AT
Microinjection of Reelin into the mPFC prevents MK-801-induced recognition memory impairment in mice
Autor:
Masahito Sawahata, Mitsuharu Hattori, Toshitaka Nabeshima, Taku Nagai, Kiyofumi Yamada, Norimichi Ito, Hiroki Asano, Takao Kohno
Publikováno v:
Pharmacological research. 173
Reelin, a large extracellular matrix protein, helps to regulate neuronal plasticity and cognitive function. Several studies have shown that Reelin dysfunction, resulting from factors such as mutations in gene RELN or low Reelin expression, is associa
Publikováno v:
Journal of Natural Language Processing. 25:555-576
Autor:
Takahiro Hiraoka, Hiroki Asano, Tomohiro Ogami, Shinichiro Nakano, Yoshifumi Okamoto, Yoshiaki Yamada, Tetsuro Oshika
Publikováno v:
Journal of Clinical Medicine; Volume 11; Issue 3; Pages: 710
Journal of Clinical Medicine, Vol 11, Iss 710, p 710 (2022)
Journal of Clinical Medicine, Vol 11, Iss 710, p 710 (2022)
The influence of dry eye disease (DED) on ocular biometric measurements is unclear. We aimed to investigate the effect of DED on the repeatability of ocular biometric measurements in cataract patients. Overall, 114 eyes scheduled for cataract surgery
Publikováno v:
IEEJ Transactions on Electrical and Electronic Engineering. 13:1633-1641